We are combining our world-renowned expertise in chemistry and pharmacology to enhance therapies to benefit patients locally, nationally, and globally. The University of Liverpool's new Therapeutics Innovation Frontier will streamline collaboration and enable industry partners to engage with us through open innovation platforms.

Our strategic partnerships have the potential to deliver transformative impact. Building on Liverpool City Region’s outstanding track record for conducting specialised clinical trials, the University is bringing together world-leading clinical academics and hospitals to develop next generation therapeutics.

The platform's overarching aim is to improve drug development and the delivery pathway.

Professor Shampa Das, Professor of Antimicrobial Therapeutics